Skip to main content
Fig. 2 | Annals of Microbiology

Fig. 2

From: Characterization of Limosilactobacillus fermentum for anti-cancer activity using HCT 116 from Egyptian dairy products

Fig. 2

The time- and dose-dependent anti-proliferative effect of Limosilactobacillus fermentum RE 245 (Accession No.215810), Limosilactobacillus fermentum RE 280 (Accession No.215848), and 5-FU on HCT-116 cells was evaluated by MTT assay for 48 and 72 h. control: untreated HCT-116 cells (human colon cancer cells); 5-FU: used as a positive control. The p-values determined using Student’s t-test were *p < 0.05, statistically significant

Back to article page